Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Mediterranean Journal of Hematology and Infectious Diseases|June 1, 2011
Invasive Candida infections in patients with haematological malignancies and hematopoietic stem cell transplant recipients: current epidemiology and therapeutic optionsCorrado Girmenia, Erica Finolezzi, Vincenzo Federico, et al.
Acta Haematologica|June 27, 2018
Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis?Sabrina Mariani, Giovanna Palumbo, Luisa Cardarelli, et al.
Leukemia Research|December 9, 2008
Achievement of complete molecular responses in late chronic phase chronic myeloid leukaemia patients treated with pulsed imatinib while in minimal residual diseaseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.
Leukemia & Lymphoma|March 23, 2010
Refractory cytopenia with unilineage dysplasia: analysis of prognostic factors and survival in 126 patientsMassimo Breccia, Roberto Latagliata, Laura Cannella, et al.
Leukemia & Lymphoma|December 5, 2008
Differences in hematological and non-hematological toxicity during treatment with imatinib in patients with early and late chronic phase chronic myeloid leukemiaMassimo Breccia, Caterina Stefanizzi, Laura Cannella, et al.
Cancer Chemotherapy and Pharmacology|November 8, 2008
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib doseMassimo Breccia, Daniela Cilloni, Laura Cannella, et al.
Hematological Oncology|September 4, 2009
Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard doseMassimo Breccia, Laura Cannella, Caterina Stefanizzi, et al.
Cancer Chemotherapy and Pharmacology|January 22, 2009
Sequential development of mutant clones in an imatinib resistant chronic myeloid leukaemia patient following sequential treatment with multiple tyrosine kinase inhibitors: an emerging problem?Massimo Breccia, Anna Maria Frustaci, Laura Cannella, et al.
European Journal of Haematology|August 12, 2020
Treatment and prognosis of primary pulmonary lymphoma: A long-term follow-up studyMichelina Santopietro, Sofia Kovalchuk, Roberta Battistini, et al.
Mediterranean Journal of Hematology and Infectious Diseases|June 30, 2011
Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phaseMassimo Breccia, Corrado Girmenia, Roberto Latagliata, et al.
Pageof 3